MANZIN, ALDO
 Distribuzione geografica
Continente #
EU - Europa 133.877
NA - Nord America 11.836
AS - Asia 5.587
SA - Sud America 740
Continente sconosciuto - Info sul continente non disponibili 440
AF - Africa 259
OC - Oceania 7
Totale 152.746
Nazione #
IT - Italia 130.818
US - Stati Uniti d'America 11.632
SG - Singapore 2.109
CN - Cina 2.005
UA - Ucraina 784
BR - Brasile 559
SE - Svezia 554
VN - Vietnam 430
GB - Regno Unito 398
FI - Finlandia 340
DE - Germania 331
FR - Francia 289
HK - Hong Kong 211
BD - Bangladesh 157
IN - India 156
KR - Corea 144
CA - Canada 111
NG - Nigeria 100
NL - Olanda 87
AR - Argentina 70
MA - Marocco 51
RU - Federazione Russa 49
IQ - Iraq 48
MX - Messico 48
TR - Turchia 44
PL - Polonia 40
ZA - Sudafrica 38
JP - Giappone 36
PK - Pakistan 34
CO - Colombia 27
AT - Austria 26
ES - Italia 26
BE - Belgio 25
SA - Arabia Saudita 22
VE - Venezuela 22
EC - Ecuador 20
KE - Kenya 18
PH - Filippine 18
ID - Indonesia 17
JO - Giordania 16
MY - Malesia 16
TH - Thailandia 16
UZ - Uzbekistan 15
CZ - Repubblica Ceca 14
IE - Irlanda 14
RO - Romania 14
CL - Cile 12
IR - Iran 12
JM - Giamaica 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
KZ - Kazakistan 10
MU - Mauritius 10
TW - Taiwan 10
EG - Egitto 9
TN - Tunisia 9
AL - Albania 8
IL - Israele 8
LT - Lituania 8
PT - Portogallo 8
UY - Uruguay 8
AZ - Azerbaigian 7
CH - Svizzera 7
CR - Costa Rica 7
GT - Guatemala 7
NO - Norvegia 7
PE - Perù 7
AU - Australia 6
DZ - Algeria 6
BG - Bulgaria 5
SK - Slovacchia (Repubblica Slovacca) 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LV - Lettonia 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
KW - Kuwait 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
BH - Bahrain 2
HN - Honduras 2
KH - Cambogia 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
Totale 152.289
Città #
Cagliari 126.103
Uta 3.607
Singapore 1.231
Ashburn 1.090
Fairfield 985
Chandler 810
San Jose 780
Dallas 625
Woodbridge 607
Houston 605
Boardman 548
Ann Arbor 429
Wilmington 399
Jacksonville 398
Seattle 369
Cambridge 334
Beijing 324
Nyköping 313
Los Angeles 289
Hefei 263
Council Bluffs 238
Helsinki 204
Hong Kong 193
Santa Clara 172
The Dalles 157
New York 154
Nanjing 140
Lauterbourg 132
Shanghai 129
Milan 127
Seoul 124
Ho Chi Minh City 116
Boston 111
Dearborn 99
Buffalo 96
Hanoi 94
Columbus 88
San Diego 75
Rome 70
Munich 68
Washington 57
Shenyang 56
São Paulo 55
Chicago 52
Verona 50
Hangzhou 47
Jiaxing 47
Hebei 43
Frankfurt am Main 42
Pune 42
Guangzhou 41
Nanchang 39
London 38
Changsha 34
Nuremberg 34
Orem 33
Tianjin 33
Toronto 33
Warsaw 33
Casablanca 32
Da Nang 29
Tokyo 29
Atlanta 28
Brooklyn 28
Redondo Beach 27
Amsterdam 26
Montreal 26
Phoenix 25
Sassari 25
Zhengzhou 25
Dong Ket 24
Stockholm 24
Brussels 23
Chennai 23
Wuhan 23
Turku 22
Jinan 21
Johannesburg 21
Haiphong 20
Denver 18
Dhaka 18
Dolianova 18
Manchester 17
Redwood City 17
Augusta 16
Mexico City 16
Norwalk 16
Rio de Janeiro 16
Dublin 15
Nairobi 15
Ningbo 15
Paris 15
Vienna 15
Amman 14
Baghdad 14
Charlotte 14
Naples 14
Poplar 14
Port Harcourt 14
Biên Hòa 13
Totale 144.330
Nome #
null 4.609
GUT MICROBIAL PROFILE IN WEIGHT CYCLING PATIENTS WITH OBESITY 4.553
Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients 3.955
H-1 NMR spectroscopy-based metabolomics analysis for the diagnosis of symptomatic E. coli-associated urinary tract infection (UTI) 3.852
Caratterizzazione di un ceppo di Listeria monocytogenes isolato da emocoltura 3.295
Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin 3.045
Usefulness of capillary electrophoresis-based multiplex PCR assay for species-specific identification of Candida spp. 2.666
RT-QuIC assay for the detection of PrPsCJD spiked into human urine 2.603
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.583
Role of PCR in Helicobacter pylori diagnostics and research - new approaches for study of coccoid and spiral forms of the bacteria 2.476
null 2.467
Streptococcus suis meningitis without history of animal contact, Italy 2.429
Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study 2.389
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease 2.381
Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman 2.353
Global impact of Torque teno virus infection in wild and domesticated animals 2.304
Distinct signatures of the gut microbiome in an Italian cohort of patients with Parkinson’s Disease 2.183
Dynamics of TT virus infection in a cohort of HCV-infected patients achieving sustained virologic responce after treatment with direct-acting antivirals 2.174
High prevalence of co-infection with multiple torque teno sus virus species in Italian pig herds 2.172
Gut microbiome signatures, clinical phenotypes and drugs in Parkinson’s disease 2.101
Impact of a Moderately Hypocaloric Mediterranean Diet on the Gut Microbiota Composition of Italian Obese Patients 2.062
Lack of KIs virus DNA in plasma and cerebrospinal fluid in Italy 1.957
Cyclovirus Vietnam DNA in immunodeficient patients 1.935
RT-QuIC assay for the in vivo detection of PrPsCJD from the cerebrospinal fluid of CJD-suspected cases at early clinical stage of disease 1.934
Lack of usutu virus RNA in cerebrospinal fluid of patients with encephalitis of unknown etiology, Tuscany, Italy 1.845
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.705
Bovine viral diarrhea virus (BVDV): A preliminary study on antiviral properties of some aromatic and medicinal plants 1.606
Epitope mapping of human antibody response against HCV/E2 glycoproteinby generation of monoclonal recombinant fabs 1.454
Human Arthropod-Borne Viral Infections 1.434
Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I) 1.421
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.342
Composite structure of Streptococcus pneumoniae containing the erythromycin efflux resistance gene mefI and the chloramphenicol resistance gene catQ 1.298
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy 1.246
Viroidi, Virus dell'epatite E e Poxviridae 1.235
New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci 1.224
High incidence of EBV-reactivation and PTLD in adults receiving a cord blood transplant with reduced-intensity conditioning regimen 1.198
Human Arthropod-Borne Viral Infections 1.163
Genetic diversity of Streptococcus suis clinical isolates from pigs and humans in Italy (2003-2007) 1.116
Metabolic Alteration in Plasma and Biopsies From Patients With IBD 1.089
Determinazione quantitativa di HCV-RNA: valutazione comparativa dei saggi Abbott Real-Time e Versant bDNA v.3 1.085
Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy 1.065
Gut microbiota markers associated with obesity and overweight in Italian adults 1.021
Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes 1.000
Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation 989
Clinical phenotypes of Parkinson’s disease associate with distinct gut microbiota and metabolome enterotypes 958
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 951
Uncomplicated UTIs and old antimicrobials: a retrospective study on southern Sardinian population 928
Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel 906
Bichromonol, a dimeric coumarin with anti-HIV activity from the stem bark of Hypericum roeperianum 905
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs 881
Gut Microbiota Markers and Dietary Habits Associated with Extreme Longevity in Healthy Sardinian Centenarians 878
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 857
Metabolomic profile of systemic sclerosis patients 836
SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated 822
LONG-TERM BENEFICIAL EFFECTS IN SUSTAINED RESPONDERS TO INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS C 817
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose 770
Dynamics of Gut Microbiota and Clinical Variables after Ketogenic and Mediterranean Diets in Drug-Naïve Patients with Type 2 Diabetes Mellitus and Obesity 768
More evidence on safety of intramascular immune serum globulin produced from plasma unscreened for anti-hepatitis C virus antibodies 758
Non-neutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs 734
null 728
Anthraquinone Rhein Exhibits Antibacterial Activity against Staphylococcus aureus 717
Parkinson’s disease: A prionopathy? 704
Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients 678
Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets 678
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 668
QUANTITATIVE LIVER PARAMETERS OF HCV INFECTION: RELATION TO HCV GENOTYPES, VIREMIA AND RESPONSE TO INTERFERON TREATMENT 658
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C 654
Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro 635
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease 626
TOFE HUMAN-B-CELL-LINE-BASED ADSORPTION-INHIBITION ASSAY TO DETECT HCV NEUTRALIZING ANTIBODIES 624
Dynamics of hepatitis C viremia after plasma exchange 622
Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania Region of Italy 621
Hepatitis C virus infection after orthotopic liver transplantation | [L'INFEZIONE DA VIRUS DELL'EPATITE C DOPO TRAPIANTO ORTOTOPICO DI FEGATO] 605
Antimicrobial effectiveness of ozonated olive and sunflower seeds oils 602
Dissection of human humoral immuneresponse against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments 600
Long-term lymphoblastoid interferon-α therapy for non-cirrhotic chronic hepatitis C: An Italian multicentre study on dose and duration of IFNα treatment 589
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection 587
Exacerbation of chronic hepatitis D during interferon alpha administration 586
Spike-mediated viral membrane fusion is inhibited by a specific anti-IFITM2 monoclonal antibody 579
PROPHYLAXIS OF HEPATITIS C WITH INTRAMUSCULAR IMMUNOGLOBULIN: CLINICAL AND ECONOMIC APPRAISAL 560
null 552
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic 548
null 547
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange 532
Evolution of hypervariable region 1 of hepatitis C virus in primary infection 526
null 526
SEXUAL TRANSMISSION OF HEPATITIS C VIRUS AND PREVENTION WITH INTRAMUSCULAR IMMUNOGLOBULIN 524
Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses 512
null 512
Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact 506
null 504
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy 495
Physico-Chemical Investigation and Antimicrobial Efficacy of Ozonated Oils: The Case Study of Commercial Ozonated Olive and Sunflower Seed Refined Oils 492
RiV4PoC: A high effective microbicidal coating for high-touch surfaces 491
QUANTITATIVE ANALYSIS OF HEPATITIS C VIRUS ACTIVITY IN VIVO IN DIFFERENT GROUPS OF UNTREATED PATIENTS 484
Design of Three Residues Peptides against SARS-CoV-2 Infection 483
PCR ANALYSIS OF HBV INFECTED SERA: RELATIONSHIP BETWEEN EXPRESSION OF PRE-S ANTIGENS AND VIRAL REPLICATION 471
null 470
α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients 469
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction 469
Totale 126.217
Categoria #
all - tutte 220.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.754 0 627 550 722 993 618 406 554 875 1.074 1.183 1.152
2022/202314.215 935 1.613 1.765 1.074 1.087 1.432 751 1.394 1.162 995 1.359 648
2023/202415.598 833 571 645 1.072 1.541 3.022 1.691 1.412 735 1.264 1.436 1.376
2024/202529.609 6.014 9.199 3.827 3.489 1.568 1.757 1.765 275 330 338 367 680
2025/202612.679 744 718 1.225 951 896 917 2.973 691 957 1.213 865 529
2026/2027724 225 499 0 0 0 0 0 0 0 0 0 0
Totale 152.746